Low Quantitative Blush Evaluator score predicts larger infarct size and reduced left ventricular systolic function in patients with STEMI regardless of diabetes status

Type 2 diabetes mellitus (T2DM) and diminished myocardial perfusion increase the risk of heart failure (HF) and/or all-cause mortality during 6-year follow up following primary percutaneous coronary intervention (pPCI) for ST elevation myocardial infarction (STEMI). The aim of the present study was to evaluate the impact of myocardial perfusion on infarct size and left ventricular ejection fraction (LVEF) in patients with T2DM and STEMI treated with pPCI. This is an ancillary analysis of an observational cohort study of T2DM patients with STEMI. We enrolled 406 patients with STEMI, including 104 with T2DM. Myocardial perfusion was assessed with the Quantitative Myocardial Blush Evaluator (QUBE) and infarct size with the creatine kinase myocardial band (CK-MB) maximal activity and troponin area under the curve. LVEF was measured with biplane echocardiography using Simpson’s method at admission and hospital discharge. Analysis of covariance was used for modeling the association between myocardial perfusion, infarct size and left ventricular systolic function. Patients with T2DM and diminished perfusion (QUBE below median) had the highest CK-MB maximal activity (252.7 ± 307.2 IU/L, P < 0.01) along with the lowest LVEF (40.6 ± 10.0, P < 0.001). Older age (p = 0.001), QuBE below median (p = 0.026), and maximal CK-MB activity (p < 0.001) were independent predictors of LVEF. Diminished myocardial perfusion assessed by QuBE predicts significantly larger enzymatic infarct size and lower LVEF among patients with STEMI treated with pPCI, regardless of diabetes status.

• Publication year

  2023

• Venue

  Scientific Reports

• Publication date

  2023-01-05

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/s41598-022-24855-6PMID 36604458PMCID 9816310
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Relation between myocardial blood flow and cardiac events in diabetic patients with suspected coronary artery disease and normal myocardial perfusion imaging

  2021cited by this paper
• Effect of Diabetes Mellitus and Left Ventricular Perfusion on Frequency of Development of Heart Failure and/or All-cause Mortality Late After Acute Myocardial Infarction.

  2020cited by this paper
• SGLT2 Inhibitor, Canagliflozin, Attenuates Myocardial Infarction in the Diabetic and Nondiabetic Heart

  2019cited by this paper
• ACEF score adapted to ST-elevation myocardial infarction patients: The ACEF-STEMI score.

  2018cited by this paper
• 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC).

  2018cited by this paper
• The multimorbidity interaction severity index (MISI)

  2017cited by this paper
• Relationship between diabetes and ischaemic injury among patients with revascularized ST‐elevation myocardial infarction

  2017cited by this paper
• Comparative analysis of biochemical parameters in diabetic and non-diabetic acute myocardial infarction patients.

  2016cited by this paper
• Coronary microvascular obstruction in acute myocardial infarction.

  2016cited by this paper
• Outcomes in diabetic patients undergoing primary percutaneous coronary intervention for acute anterior myocardial infarction: Results from the INFUSE‐AMI study

  2014cited by this paper
• Comparison of the frequencies of myocardial edema determined by cardiac magnetic resonance in diabetic versus nondiabetic patients having percutaneous coronary intervention for ST elevation myocardial infarction.

  2014cited by this paper
• Impact of Diabetes on Long-Term Outcome After Primary Angioplasty

  2013cited by this paper
• Quantitative myocardial blush score (QuBE) allows the prediction of heart failure development in long-term follow-up in patients with ST-segment elevation myocardial infarction: Proof of concept study

  2013cited by this paper
• Left ventricular systolic and diastolic function, remodelling, and clinical outcomes among patients with diabetes following myocardial infarction and the influence of direct renin inhibition with aliskiren

  2012cited by this paper
• Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction.

  2012cited by this paper
• Diabetes mellitus, myocardial reperfusion, and outcome in patients with acute ST-elevation myocardial infarction treated with primary angioplasty (from HORIZONS AMI).

  2012cited by this paper
• Prognostic Impact of Hyperglycemia in Nondiabetic and Diabetic Patients With ST-Elevation Myocardial Infarction: Insights From Contrast-Enhanced Magnetic Resonance Imaging

  2012cited by this paper
• Impact of chronic total occlusions on markers of reperfusion, infarct size, and long‐term mortality: A substudy from the TAPAS‐trial

  2011cited by this paper
• Quantitative Blush Evaluator accurately quantifies microvascular dysfunction in patients with ST-elevation myocardial infarction: comparison with cardiovascular magnetic resonance.

  2011cited by this paper
• The relation between myocardial blush grade and myocardial contrast echocardiography: which one is a better predictor of myocardial damage?

  2010cited by this paper
• The inter‐relationship of diabetes and left ventricular systolic function on outcome after high‐risk myocardial infarction

  2010cited by this paper
• Diabetes mellitus is associated with distal embolization, impaired myocardial perfusion, and higher mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty and glycoprotein IIb-IIIa inhibitors.

  2009cited by this paper
• Computer-assisted myocardial blush quantification after percutaneous coronary angioplasty for acute myocardial infarction: a substudy from the TAPAS trial.

  2009cited by this paper
• GLP-1R Agonist Liraglutide Activates Cytoprotective Pathways and Improves Outcomes After Experimental Myocardial Infarction in Mice

  2009cited by this paper
• Functional recovery after acute myocardial infarction: comparison between angiography, electrocardiography, and cardiovascular magnetic resonance measures of microvascular injury.

  2008cited by this paper
• Reperfusion after primary angioplasty for ST-elevation myocardial infarction: predictors of success and relationship to clinical outcomes in the APEX-AMI angiographic study.

  2008cited by this paper
• Infarct size, ejection fraction, and mortality in diabetic patients with acute myocardial infarction treated with thrombolytic therapy.

  2007cited by this paper
• Does personality predict mortality? Results from the GAZEL French prospective cohort study.

  2007cited by this paper
• Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study

  2007cited by this paper
• Comparison of myocardial reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus (from the EMERALD Trial).

  2007cited by this paper
• Primary percutaneous coronary intervention compared with fibrinolysis for myocardial infarction in diabetes mellitus: results from the Primary Coronary Angioplasty vs Thrombolysis-2 trial.

  2007cited by this paper
• Combination of electrocardiographic and angiographic markers of reperfusion in the prediction of infarct size in patients with ST-segment elevation myocardial infarction undergoing successful primary angioplasty.

  2007cited by this paper
• Postprandial Myocardial Perfusion in Healthy Subjects and in Type 2 Diabetic Patients

  2005cited by this paper
• Impact of diabetes mellitus on myocardial perfusion after primary angioplasty in patients with acute myocardial infarction.

  2005cited by this paper
• Long-term, cause-specific mortality after myocardial infarction in diabetes.

  2004cited by this paper
• Relationship of infarct size and severity versus left ventricular ejection fraction and volumes obtained from 99mTc-sestamibi gated single-photon emission computed tomography in patients treated with primary percutaneous coronary intervention

  2004cited by this paper
• Impact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunction.

  2004cited by this paper
• Angiographic Assessment of Reperfusion in Acute Myocardial Infarction by Myocardial Blush Grade

  2003cited by this paper
• The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis.

  2002cited by this paper
• Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs.

  2000cited by this paper
• Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group.

  1998cited by this paper
• Clinical Implications of the ‘No Reflow’ Phenomenon

  1996cited by this paper
• Clinical implications of the 'no reflow' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction.

  1996cited by this paper

• Thrombolysis in Myocardial Infarction (TIMI) Flow and Myocardial Blush (MB) as Predictors of Left Ventricular Ejection Fraction Improvement in Patients with Acute Myocardial Infarction with ST Segment Elevation Undergoing Primary Percutaneous Coronary Intervention

  2026cites this paper
• Impact of oral nicorandil administration prior to primary percutaneous coronary intervention on no-reflow: a randomized controlled trial.

  2025cites this paper
• Differential gene expression patterns in ST-elevation Myocardial Infarction and Non-ST-elevation Myocardial Infarction

  2024cites this paper